Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVD 37000: Immunity and Microbiome Studies in Ty21a Vaccinated Adults
NCT03970304Phase 4Active, not recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2013
- Primary completion
- Aug 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of typhoid vaccine, live oral in typhoid fever (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Percentage of Responders at 5 years. Started Oct 2013; status: active, not recruiting.
02
Drugs
typhoid vaccine, live oral
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03970304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970304.